Company
Holobiome
The leader in microbiome-based therapies for mental health, with a pipeline targeting depression, anxiety, and chronic pain via the gut-brain axis.
Also known as Holobiome, Inc.
Claim, correct or request removal
Record updated 17 September 2026
About
The leader in microbiome-based therapies for mental health, with a pipeline targeting depression, anxiety, and chronic pain via the gut-brain axis.
Funding snapshot
- Total raised
- $10.5MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Seed, $9M
Funding rounds
- Round, 2024
- $6.6M2024-03-14, SEC form D sold, 19 investors
- Round, 2021
- $300K2021-02-01, SEC form D sold, 2 investors
- Round, 2018
- $625K2018-12-17, SEC form D sold, 1 investor
- Grant
- $1MCompany stated
- Grant
- $500KCompany stated
- Seed
- $9MCompany stated
Loading relationship preview